http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dceb4c3e3a19abc21ebe175e2c36a583
Outgoing Links
Predicate | Object |
---|---|
family-name | Drayson Mark T. Drayson |
name | Mark T Drayson Mark T. Drayson |
given-name | Mark T Mark T. |
organization-name | Medical Research Council Centre for Immune Regulation and Clinical Immunology Service Institute of Biomedical Research School of Immunity and Infection College of Medicine and Dental Sciences University of Birmingham Birmingham UK Medical Research Council Centre for Immune Regulation and Clinical Immunology Service, Institute of Biomedical Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom; 5Clinical Immunology, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom. University of Birmingham, Birmingham, UK. Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK Clinical Immunology, School of Immunity and Infection, University of Birmingham, UK. University of Birmingham, Birmingham, United Kingdom; Division of Immunity and Infection, Birmingham University Medical School, Vincent Drive, Edgbaston, Birmingham B15 2TT, United Kingdom; and Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, United Kingdom Clinical Immunology Service, Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's... School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom Institute of Immunology and Immunotherapy, University of Birmingham, United Kingdom (M.T.D.). Department of Immunology, The Medical School, Edgbaston, Birmingham B15 2TT, United Kingdom Section of Experimental Haematology (TYPO), Leeds Insitute of Cancer & Pathology, Univeristy of Leeds Leeds UK University of Birmingham, Birmingham, United Kingdom; and School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom From The Department of Immunology and Cancer Research United Kingdom Clinical Trials Unit, the University of Birmingham, Birmingham; Section of Haemato-Oncology Institute for Cancer Research, Royal Marsden Hospital, London; the Department of Haematology, St Helier Hospital National Health Service Trust, Carshalton, Surrey; and the Department of Haematology Southampton University National Health Service Trust, Southampton, United Kingdom Clinical Immunology, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom; Authors' Affiliations: 1Institute of Cancer Research, Royal Marsden Hospital, London; 2Clinical Trials Research Unit, University of Leeds; 3St James's University Hospital, Leeds; 4University of Birmingham, Birmingham; 5Wessex Regional Genetics Laboratory, University of Southampton, Salisbury; and 6University of Newcastle, Newcastle-upon-Tyne, United Kingdom Institute of Immunology and Immunotherapy College of Medical and Dental Sciences University of Birmingham Birmingham UK University of Birmingham, Birmingham, United Kingdom Department of Immunology, University of Birmingham, Birmingham B15 2TT, UK Institute of Immunology and Immunotherapy University of Birmingham, Edgbaston Birmingham UK Division of Immunity and Infection University of Birmingham Birmingham UK Authors' Affiliations: 1School of Biosciences and 2Division of Immunity and Infection, University of Birmingham, Edgbaston, Birmingham, United Kingdom; and 3Division of Hematology and Oncology, Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California Institute of Immunology and Immunotherapy, University of Birmingham , Birmingham, West Midlands , UK University of Birmingham Birmingham UK Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. Division of Immunity & InfectionThe Medical SchoolUniversity of Birmingham Birmingham United Kingdom Department of Immunology; University of Birmingham; Birmingham UK Andy C. Rawstron, Ruth M. de Tute, Gordon Cook, and Roger G. Owen, St James's University Hospital; J. Anthony Child, Walter M. Gregory, Sue E. Bell, Alexander J. Szubert, and Nuria Navarro-Coy, University of Leeds, Leeds; Faith E. Davies and Gareth J. Morgan, Institute of Cancer Research, London; Mark T. Drayson, University of Birmingham, Birmingham; Sylvia Feyler, Calderdale and Huddersfield National Health Service Trust, Huddersfield; Fiona M. Ross, Wessex Regional Genetics Laboratory, Salisbury; and... School of Immunity and Infection College of Medical and Dental Sciences University of Birmingham Birmingham UK 10Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom;; 11Clinical Immunology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; From the Medical Research Council (MRC) Centre for Immune Regulation, School of Biosciences, and Division of Neurosciences, The Medical School, University of Birmingham, Birmingham, United Kingdom; and the MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom. Medical Research Council Centre for Immune Regulation and Clinical Immunology Service, Institute of Biomedical Research, School of Immunity and Infection, University of Birmingham, Birmingham, UK. Institute of Immunology and Immunotherapy, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom Clinical Immunology Service, University of Birmingham Medical School, Edgbaston, United Kingdom; and School of Immunity and Infection, University of Birmingham, Birmingham, UK. Electronic address: m.t.drayson@bham.ac.uk. Clinical Immunology Service, University of Birmingham Medical School, Birmingham, United Kingdom; Clinical Immunology Service University of Birmingham Birmingham UK School of Immunity and Infection University of Birmingham Birmingham UK Department of Immunity and Infection, Medical School, University of Birmingham, UK Clinical Immunology, University of Birmingham, Birmingham, UK. Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom. Institute of Immunity and Immunotherapy, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom;; Clinical Immunology Service, School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; Clinical Immunology Service Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham , Birmingham, UK Clinical Immunology Service, School of Immunity and Infection, University of Birmingham, Birmingham, UK; 3School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom. Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK. From the Academic Unit of Haematology and Oncology, University of Leeds, United Kingdom; Department of Haematology, Hull Royal Infirmary, United Kingdom; and Department of Immunology, University of Birmingham, United Kingdom. Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Department of Clinical Immunology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK Clinical Immunology Service Institute of Immunology and Immunotherapy University of Birmingham Medical School Birmingham UK; Department of Clinical Immunology University Hospitals Birmingham NHS Foundation Trust Birmingham UK |
Incoming Links
Total number of triples: 247.